HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, has announced the launch of FibroSIGHT™ Plus, its second Laboratory Developed Test (LDT)...
Tempus AI, Inc., a leader in artificial intelligence and precision medicine, announced that its multimodal immune profile score (IPS) algorithmic test is now available...
Tempus AI, Inc., a leader in artificial intelligence and precision medicine, announced that the company’s PurIST algorithmic test has received a proprietary laboratory analysis...